Provided by Tiger Fintech (Singapore) Pte. Ltd.

Addex Therapeutics Ltd

7.79
+0.10211.33%
Volume:2.34K
Turnover:19.27K
Market Cap:8.33M
PE:1.04
High:8.59
Open:8.30
Low:7.79
Close:7.69
Loading ...

Addex Therapeutics enters collaboration with Sinntaxis AB

TIPRANKS
·
Yesterday

Addex Enters Option Agreement with Sinntaxis for an Exclusive License to Intellectual Property Covering the Use of mGlu5 Inhibitors in Brain Injury Recovery

GlobeNewswire
·
Yesterday

Addex Reports Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
25 Apr

Addex Therapeutics to Release Full-Year 2024 Financial Results and Host Conference Call on April 25, 2025

GlobeNewswire
·
24 Apr

Addex Reclaims Rights to Epilepsy Drug as Janssen Ends Partnership

MT Newswires Live
·
17 Apr

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

GlobeNewswire
·
17 Apr

Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview

Reuters
·
04 Apr

Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview

Reuters
·
21 Mar

Addex to Present at the 2025 Swiss Equities Baader Conference

GlobeNewswire
·
08 Jan

Top Premarket Decliners

MT Newswires Live
·
27 Dec 2024

Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?

Zacks
·
27 Nov 2024

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...

GuruFocus.com
·
23 Nov 2024

Addex Therapeutics GAAP EPS of -CHF0.02, revenue of CHF0.06M

seekingalpha
·
22 Nov 2024

Addex Therapeutics Reported Q3 EPS Of CHF(0.02) Up From CHF(0.03), Cash Balance Of CHF3.35M

Benzinga
·
22 Nov 2024

Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview

Reuters
·
20 Nov 2024

Are Medical Stocks Lagging Addex Therapeutics (ADXN) This Year?

Zacks
·
11 Nov 2024

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

GlobeNewswire
·
11 Nov 2024

Addex Therapeutics Ltd expected to post a loss of 1 rappen a share - Earnings Preview

Reuters
·
09 Nov 2024